Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 18, 2003

View Archived Issues

First patient enrolled in PRoFESS stroke prevention trial

Grants support work on ricin vaccine technology

Odyssey and Dharmacon investigate effects of siRNA-induced gene silencing

Aastrom receives SBIR grant for dendritic cell vaccine research

Access and Celltech enter oral drug delivery research collaboration

Tulobuterol tape found to induce no effects on the airway hyperresponsiveness of asthmatic children

Use of pregabalin in patients with partial seizures or pain

Ximelagatran prevents recurrence of cardiovascular events after myocardial infarction

Potential benefits described for KB-130015 in the treatment of atrial fibrillation

Reduced risk of cardiovascular death and MI reported for perindopril in stable coronary disease

Topical amitriptyline has analgesic effects in healthy volunteers

Limited activity described for exatecan mesilate as first-line monotherapy in NSCLC

Seasonale receives FDA approval

Japan Tobacco discontinues JTE-522 development

Arava launched in Japan

Acambis updates product development highlights

New agents with utility in urinary incontinence patented by Boehringer Ingelheim

Valproic acid analogues and their use in epilepsy and other disorders

New IgE production inhibitors in early development at Novartis

Pfizer reports preparation and testing of new ORL1 antagonists

New FAP-activated prodrugs of antitumor agents claimed by Boehringer Ingelheim

Novel glucocorticoid agonists and their use

Developments at Micrologix Biotech

Structurally novel vascular targeting agent discovered by Oxigene and Baylor U.

BMS-561389/DPC-906 as a phase II candidate for oral anticoagulant therapy

Promising new antifungal series presented by Genelabs at ICAAC meeting

GSQ-7302, a new SMAT with strong antipneumococcal activity

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...